130 related articles for article (PubMed ID: 29192194)
1. Solution structure and interaction with copper in vitro and in living cells of the first BIR domain of XIAP.
Hou MM; Polykretis P; Luchinat E; Wang X; Chen SN; Zuo HH; Yang Y; Chen JL; Ye Y; Li C; Banci L; Su XC
Sci Rep; 2017 Nov; 7(1):16630. PubMed ID: 29192194
[TBL] [Abstract][Full Text] [Related]
2. Third BIR domain of XIAP binds to both Cu(II) and Cu(I) in multiple sites and with diverse affinities characterized at atomic resolution.
Chen SN; Fang T; Kong JY; Pan BB; Su XC
Sci Rep; 2019 May; 9(1):7428. PubMed ID: 31092843
[TBL] [Abstract][Full Text] [Related]
3. Copper-binding properties of the BIR2 and BIR3 domains of the X-linked inhibitor of apoptosis protein.
Liang Y; Ewing PM; Laursen WJ; Tripp VT; Singh S; Splan KE
J Inorg Biochem; 2014 Nov; 140():104-10. PubMed ID: 25105866
[TBL] [Abstract][Full Text] [Related]
4. Crystal structure of the BIR1 domain of XIAP in two crystal forms.
Lin SC; Huang Y; Lo YC; Lu M; Wu H
J Mol Biol; 2007 Sep; 372(4):847-854. PubMed ID: 17698078
[TBL] [Abstract][Full Text] [Related]
5. Disruption of zinc (II) binding and dimeric protein structure of the XIAP-RING domain by copper (I) ions.
Splan KE; Choi SR; Claycomb RE; Eckart-Frank IK; Nagdev S; Rodemeier ME
J Biol Inorg Chem; 2023 Aug; 28(5):485-494. PubMed ID: 37268744
[TBL] [Abstract][Full Text] [Related]
6. Targeting the X-linked inhibitor of apoptosis protein through 4-substituted azabicyclo[5.3.0]alkane smac mimetics. Structure, activity, and recognition principles.
Mastrangelo E; Cossu F; Milani M; Sorrentino G; Lecis D; Delia D; Manzoni L; Drago C; Seneci P; Scolastico C; Rizzo V; Bolognesi M
J Mol Biol; 2008 Dec; 384(3):673-89. PubMed ID: 18851976
[TBL] [Abstract][Full Text] [Related]
7. Integrity of XIAP is essential for effective activity recovery of apoptosome and its downstream caspases by Smac/Diablo.
Attaran-Bandarabadi F; Abhari BA; Neishabouri SH; Davoodi J
Int J Biol Macromol; 2017 Aug; 101():283-289. PubMed ID: 28322955
[TBL] [Abstract][Full Text] [Related]
8. XIAP induces NF-kappaB activation via the BIR1/TAB1 interaction and BIR1 dimerization.
Lu M; Lin SC; Huang Y; Kang YJ; Rich R; Lo YC; Myszka D; Han J; Wu H
Mol Cell; 2007 Jun; 26(5):689-702. PubMed ID: 17560374
[TBL] [Abstract][Full Text] [Related]
9. Engineering ML-IAP to produce an extraordinarily potent caspase 9 inhibitor: implications for Smac-dependent anti-apoptotic activity of ML-IAP.
Vucic D; Franklin MC; Wallweber HJ; Das K; Eckelman BP; Shin H; Elliott LO; Kadkhodayan S; Deshayes K; Salvesen GS; Fairbrother WJ
Biochem J; 2005 Jan; 385(Pt 1):11-20. PubMed ID: 15485396
[TBL] [Abstract][Full Text] [Related]
10. Structural analysis of the UBA domain of X-linked inhibitor of apoptosis protein reveals different surfaces for ubiquitin-binding and self-association.
Tse MK; Hui SK; Yang Y; Yin ST; Hu HY; Zou B; Wong BC; Sze KH
PLoS One; 2011; 6(12):e28511. PubMed ID: 22194841
[TBL] [Abstract][Full Text] [Related]
11. Determination of the sequence specificity of XIAP BIR domains by screening a combinatorial peptide library.
Sweeney MC; Wang X; Park J; Liu Y; Pei D
Biochemistry; 2006 Dec; 45(49):14740-8. PubMed ID: 17144666
[TBL] [Abstract][Full Text] [Related]
12. Identification of mammalian mitochondrial proteins that interact with IAPs via N-terminal IAP binding motifs.
Verhagen AM; Kratina TK; Hawkins CJ; Silke J; Ekert PG; Vaux DL
Cell Death Differ; 2007 Feb; 14(2):348-57. PubMed ID: 16794601
[TBL] [Abstract][Full Text] [Related]
13. Mechanism of the interaction between the intrinsically disordered C-terminus of the pro-apoptotic ARTS protein and the Bir3 domain of XIAP.
Reingewertz TH; Shalev DE; Sukenik S; Blatt O; Rotem-Bamberger S; Lebendiker M; Larisch S; Friedler A
PLoS One; 2011; 6(9):e24655. PubMed ID: 21949740
[TBL] [Abstract][Full Text] [Related]
14. Building homogeneous time-resolved fluorescence resonance energy transfer assays for characterization of bivalent inhibitors of an inhibitor of apoptosis protein target.
Chaudhry C; Davis J; Zhang Y; Posy S; Lei M; Shen H; Yan C; Devaux B; Zhang L; Blat Y; Metzler W; Borzilleri RM; Talbott RL
Anal Biochem; 2016 Mar; 497():8-17. PubMed ID: 26743718
[TBL] [Abstract][Full Text] [Related]
15. Structure-activity based study of the Smac-binding pocket within the BIR3 domain of XIAP.
Wist AD; Gu L; Riedl SJ; Shi Y; McLendon GL
Bioorg Med Chem; 2007 Apr; 15(8):2935-43. PubMed ID: 17336535
[TBL] [Abstract][Full Text] [Related]
16. The structure of the BIR3 domain of cIAP1 in complex with the N-terminal peptides of SMAC and caspase-9.
Kulathila R; Vash B; Sage D; Cornell-Kennon S; Wright K; Koehn J; Stams T; Clark K; Price A
Acta Crystallogr D Biol Crystallogr; 2009 Jan; 65(Pt 1):58-66. PubMed ID: 19153467
[TBL] [Abstract][Full Text] [Related]
17. Molecular interaction between HAX-1 and XIAP inhibits apoptosis.
Kang YJ; Jang M; Park YK; Kang S; Bae KH; Cho S; Lee CK; Park BC; Chi SW; Park SG
Biochem Biophys Res Commun; 2010 Mar; 393(4):794-9. PubMed ID: 20171186
[TBL] [Abstract][Full Text] [Related]
18. Optimization of benzodiazepinones as selective inhibitors of the X-linked inhibitor of apoptosis protein (XIAP) second baculovirus IAP repeat (BIR2) domain.
Kester RF; Donnell AF; Lou Y; Remiszewski SW; Lombardo LJ; Chen S; Le NT; Lo J; Moliterni JA; Han X; Hogg JH; Liang W; Michoud C; Rupert KC; Mischke S; Le K; Weisel M; Janson CA; Lukacs CM; Fretland AJ; Hong K; Polonskaia A; Gao L; Li S; Solis DS; Aguilar D; Tardell C; Dvorozniak M; Tannu S; Lee EC; Schutt AD; Goggin B
J Med Chem; 2013 Oct; 56(20):7788-803. PubMed ID: 24093940
[TBL] [Abstract][Full Text] [Related]
19. Targeting XIAP for the treatment of malignancy.
Schimmer AD; Dalili S; Batey RA; Riedl SJ
Cell Death Differ; 2006 Feb; 13(2):179-88. PubMed ID: 16322751
[TBL] [Abstract][Full Text] [Related]
20. NMR structure and mutagenesis of the inhibitor-of-apoptosis protein XIAP.
Sun C; Cai M; Gunasekera AH; Meadows RP; Wang H; Chen J; Zhang H; Wu W; Xu N; Ng SC; Fesik SW
Nature; 1999 Oct; 401(6755):818-22. PubMed ID: 10548111
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
